Cutaneous response to recombinant interleukin 2 in human immunodeficiency virus 1-seropositive individuals.

We report that 11 human immunodeficiency virus 1 (HIV-1)-seropositive patients, including three AIDS patients, were able to generate a cellular immune response to the intradermal injection of low doses (2-10 micrograms) of recombinant interleukin 2 (rIL-2). A dose-dependent zone of induration appear...

Celý popis

Podrobná bibliografie

Vydáno v:	Proc Natl Acad Sci U S A
Hlavní autoři:	McElrath, M J, Kaplan, G, Burkhardt, R A, Cohn, Z A
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	National Academy of Sciences 1990
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC54412/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2143021/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.87.15.5783
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!